Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer - Yang, Shuo; Li, Guoli; Yin, Xin; Wang, Yufei; Jiang, Xinju; Bian, Xiulan; Fang, Tianyi; Yin, Shengjie; Zhang, Lei; Xue, Yingwei (The journal of pathology. Clinical research, 2023)
Keywords: Algorithms; Biotechnology; Cancer therapies; Cancer-Associated Fibroblasts - pathology; cancer‐associated fibroblasts; Cell Line, Tumor; Cells; Chemotherapy; Cisplatin; Cytokines; DNA microarrays; Extracellular matrix; Fibroblasts; Fructose-6-phosphate; Gastric cancer; Gastrointestinal surgery; Gene expression; Genes; Genomes; Genomics; GFPT2; Glucose; Glutamine; Glutamine - metabolism; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) - genetics; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) - metabolism; Guanylate cyclase; Humans; immune microenvironment; Immunohistochemistry; Infiltration; Lymph nodes; Metabolism; Metastases; Metastasis; Microenvironments; Original; Paclitaxel; Patients; Prognosis; Protein arrays; Proteins; RNA, Messenger - metabolism; Stomach Neoplasms - genetics; Stomach Neoplasms - pathology; Stromal cells; Transcriptomes; Tumor Microenvironment; Western blotting; China; cancer-associated fibroblasts; immune microenvironment; gastric cancer; prognosis; GFPT2